Wellness tourism is booming as travelers look for detox, weight loss programs
Wellness tourism is booming around the world as travelers look for opportunities to lose weight and detox at home and abroad.
Watch CBS News
Wellness tourism is booming around the world as travelers look for opportunities to lose weight and detox at home and abroad.
The deal, with Eli Lilly and Novo Nordisk, is expected to lower the price of obesity drugs to between $149 and $350 per month in some cases, officials said.
Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced a successful Phase 3 trial for a once-daily GLP-1 pill for diabetes and weight loss.
A Bucks County woman is speaking out after her insurance company decided to no longer cover weight loss drugs.
A major insurance company is no longer covering drugs like Zepbound prescribed solely for weight loss blaming exorbitant costs. Stephanie Stahl reports.
People who take popular weight loss drugs like Ozempic can have serious side effects and new research says stopping them can also cause problems. Now that millions of people have successfully lost weight using them, many are wondering about quitting. Stephanie Stahl has one dieter’s journey, being told on Instagram.
Popular weight loss drugs like Ozempic might be able to help with substance abuse, according to new research.
Incorrect dose calculations have resulted in patients administering 5 to 10 times more of the medication than drugmakers intended.
When diet and exercise aren't enough, doctors say some people need medical treatments to lose weight and they're concerned about diet shaming.
From the Ozempic "ripple effect" to health tech and more, experts share their predictions for 2024 wellness trends.
The medication, tirzepatide, was previously approved as Mounjaro for diabetes and will now be marketed as Zepbound for weight loss.
The new drug, Zepbound is a rebranded version of the popular Diabetes drug, Mounjaro.
New research says these drugs can cause serious, even deadly side effects.
The risk of heart attack, stroke and cardiovascular death dropped significantly in patients that took the new weight-loss drug over a five-year period.
A personal injury law firm filed a suit against Novo Nordisk and Eli Lilly and Co., the manufacturers of Ozempic and Mounjaro.
Ozempic and Wegovy both utilize the drug semaglutide, which mimics a natural hormone that slows the passage of food through the stomach, helping patients feel fuller longer.
Doctors are raising the alarm for those taking Ozempic and Wegovy for weight loss and diabetes after seeing some cases of stomach paralysis in patients who took the popular medications.
Shedding pounds isn't the only change patients might experience.
European regulators are investigating the risk of suicidal thoughts among those taking popular drugs for weight loss, like Ozempic.
Berberine is the latest supplement craze, gaining attention on social media as a "natural" weight loss option. Here's what to know, according to experts.
The research review in Circulation looked at the combined results of 124 studies with more than 50,000 people.
